<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4"><labelDrug name="TOPROLXL"><Normalization/></labelDrug><generic name="Metoprolol succinate"/><sentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.1" text="Drug Label for drug brand TOPROLXL, containing Metoprolol succinate." type="negative"><entity charOffset="47:67" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.1.e.0" text="metoprolol succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0724633" phraseText="Metoprolol succinate." preferredWord="metoprolol succinate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.1.e.1" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand TOPROLXL," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.1.e.1" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.1.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46" lineNumber="56" text="&lt;item&gt;Calcium Channel Blockers: Because of significant inotropic and chronotropic effects in patients treated with beta-blockers and calcium channel blockers of the verapamil and diltiazem type, caution should be exercised in patients treated with these agents concomitantly. " type="regular"><entity charOffset="133:157" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.1" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="calcium channel blockers of the verapamil" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="165:174" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="calcium channel blockers of the verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="179:188" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.4" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem type," preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="55:64|82:89" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.6" text="inotropic effects" type="Specific_Interaction"/><entity charOffset="115:128" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.7" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="treated with beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="69:89" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.9" text="chronotropic effects" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.2" drugClass="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.1"/><drugClassMembership drug="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.4" drugClass="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.1"/><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.7"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.ddi.2"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.7"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.7" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.1" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.46.e.6" type="Specific_Interaction"/></sentence><sentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.56" text="If such symptoms occur, increase diuretics and restore clinical stability before advancing the dose of TOPROL-XL see Dosage and Administration (2). " type="negative"><entity charOffset="33:42" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.56.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="increase diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="103:112" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.56.e.1" text="toprol-xl" type="Biomedical_Entity"><Normalization><mmtx cui="C0723783" phraseText="the dose of TOPROL-XL" preferredWord="Toprol-XL" semType="phsu, orch"/><RxNorm RxCui="220348"/></Normalization></entity><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.56.e.0" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.56.e.1"/></sentence><sentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.61" text="Because of its relative beta1 cardio-selectivity, however, TOPROL-XL may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. " type="negative"><entity charOffset="170:186" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.61.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="other antihypertensive treatment." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="59:68" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.61.e.1" text="toprol-xl" type="Biomedical_Entity"><Normalization><mmtx cui="C0723783" phraseText="TOPROL-XL" preferredWord="Toprol-XL" semType="phsu, orch"/><RxNorm RxCui="220348"/></Normalization></entity><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.61.e.1" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.61.e.0"/></sentence><sentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.63" text="Bronchodilators, including beta2-agonists, should be readily available or administered concomitantly see Dosage and Administration (2)." type="negative"><entity charOffset="0:15" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.63.e.0" text="bronchodilators" type="Biomedical_Entity"><Normalization><mmtx cui="C0006280" phraseText="Bronchodilators," preferredWord="Bronchodilator Agents" semType="phsu"/><RxNorm RxCui="1779"/></Normalization></entity><entity charOffset="33:41" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.63.e.1" text="agonists" type="Biomedical_Entity"><Normalization><mmtx cui="C2987634" phraseText="beta2-agonists," preferredWord="Agonist" semType="phsu"/><RxNorm RxCui="608609"/></Normalization></entity><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.63.e.0" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.63.e.1"/></sentence><sentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.65" text="If TOPROL-XL is used in the setting of pheochromocytoma, it should be given in combination with an alpha blocker, and only after the alpha blocker has been initiated. " type="negative"><entity charOffset="133:146" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.65.e.0" text="alpha blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="only after the alpha blocker" preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="3:12" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.65.e.1" text="toprol-xl" type="Biomedical_Entity"><Normalization><mmtx cui="C0723783" phraseText="TOPROL-XL" preferredWord="Toprol-XL" semType="phsu, orch"/><RxNorm RxCui="220348"/></Normalization></entity><entity charOffset="99:112" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.65.e.2" text="alpha blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="with an alpha blocker," preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.65.e.1" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.65.e.0"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.65.e.1" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.65.e.2"/></sentence><sentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.66" text="Administration of beta-blockers alone in the setting of pheochromocytoma has been associated with a paradoxical increase in blood pressure due to the attenuation of beta-mediated vasodilatation in skeletal muscle." type="negative"><entity charOffset="170:178" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.66.e.0" text="mediated" type="Biomedical_Entity"><Normalization><mmtx cui="C0127400" phraseText="of beta-mediated vasodilatation" preferredWord="Mediator brand of benfluorex hydrochloride" semType="phsu, orch"/><RxNorm RxCui="985488"/></Normalization></entity><entity charOffset="18:31" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.66.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="Administration of beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.66.e.1" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.66.e.0"/></sentence><sentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.78" text="While taking beta-blockers, patients with a history of severe anaphylactic reactions to a variety of allergens may be more reactive to repeated challenge and may be unresponsive to the usual doses of epinephrine used to treat an allergic reaction." type="negative"><entity charOffset="200:211" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.78.e.0" text="epinephrine" type="Biomedical_Entity"><Normalization><mmtx cui="C0014563" phraseText="unresponsive to the usual doses of epinephrine" preferredWord="Epinephrine" semType="phsu, orch, horm, nsba"/><RxNorm RxCui="362"/></Normalization></entity><entity charOffset="101:110" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.78.e.1" text="allergens" type="Biomedical_Entity"><Normalization><mmtx cui="C3274161" phraseText="of allergens" preferredWord="Allergen (brand of diphenylpyraline)" semType="phsu, orch"/><RxNorm RxCui="1297244"/></Normalization></entity><entity charOffset="13:26" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.78.e.2" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="taking beta-blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.78.e.1" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.78.e.0"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.78.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.78.e.0"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.78.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.78.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82" lineNumber="104" text="Because of significant inotropic and chronotropic effects in patients treated with beta-blockers and calcium channel blockers of the verapamil and diltiazem type, caution should be exercised in patients treated with these agents concomitantly." type="regular"><entity charOffset="23:32|50:57" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.1" text="inotropic effects" type="Specific_Interaction"/><entity charOffset="101:125" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.2" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="calcium channel blockers of the verapamil" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="83:96" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.3" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="treated with beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="37:57" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.5" text="chronotropic effects" type="Specific_Interaction"/><entity charOffset="133:142" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.7" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="calcium channel blockers of the verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="147:156" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.9" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem type," preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><drugClassMembership drug="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.7" drugClass="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.2"/><drugClassMembership drug="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.9" drugClass="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.2"/><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.ddi.2"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.5"><relations><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.2" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.82.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.84" lineNumber="111" text="&lt;item&gt;Catecholamine-depleting drugs may have an additive effect when given with beta-blocking agents. " type="regular"><entity charOffset="48:63" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.84.e.1" text="additive effect" type="Increase_Interaction"/><entity charOffset="80:100" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.84.e.2" text="beta-blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="given with beta-blocking agents." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="6:35" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.84.e.3" text="Catecholamine-depleting drugs" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="&gt;Catecholamine-depleting drugs" preferredWord="Catecholamines" semType="phsu, nsba"/><mmtx cui="C0013227" phraseText="&gt;Catecholamine-depleting drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C3536742" phraseText="&gt;Catecholamine-depleting drugs" preferredWord="Catecholamine [EPC]" semType="phsu"/><mmtx cui="C0013227" phraseText="&gt;Catecholamine-depleting drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="990350"/></Normalization></entity><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.84.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.84.e.1"><relations><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.84.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.84.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.84.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.84.e.2" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.84.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.86" lineNumber="113" text="&lt;item&gt;CYP2D6 Inhibitors are likely to increase metoprolol concentration. " type="regular"><entity charOffset="38:46|58:71" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.86.e.1" text="increase concentration" type="Increase_Interaction"/><entity charOffset="6:23" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.86.e.2" text="CYP2D6 Inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="22364"/></Normalization></entity><entity charOffset="47:57" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.86.e.3" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="metoprolol concentration." preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.86.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.86.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.86.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.86.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.86.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.86.e.3" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.86.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="5" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88" lineNumber="115" text="&lt;item&gt;Concomitant use of glycosides, clonidine, and diltiazem and verapamil with beta-blockers can increase the risk of bradycardia. " type="regular"><entity charOffset="120:131" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.1" text="bradycardia" type="Specific_Interaction"/><entity charOffset="25:35" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.2" text="glycosides" type="Drug"><Normalization><mmtx cui="C0007158" phraseText="&gt;Concomitant use of glycosides," preferredWord="Cardiac Glycosides" semType="phsu, carb"/><RxNorm RxCui="4958"/></Normalization></entity><entity charOffset="52:61" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.3" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem" preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="66:75" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil with beta-blockers" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="37:46" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.5" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="clonidine," preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="81:94" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.6" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="verapamil with beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.6" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.6" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.4" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.6" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.5" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.6" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.3"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.4"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.5"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.4"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.5" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.3"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.5" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.88.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.90" lineNumber="117" text="&lt;item&gt;Beta-blockers including metoprolol, may exacerbate the rebound hypertension that can follow the withdrawal of clonidine. " type="irregular"><entity charOffset="6:19" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.90.e.1" text="Beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="&gt;Beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="30:40" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.90.e.2" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="metoprolol," preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="61:81" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.90.e.4" text="rebound hypertension" type="Specific_Interaction"><Normalization><mmtx cui="C0520540" phraseText="the rebound hypertension" preferredWord="Rebound hypertension" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.90.e.2" drugClass="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.90.e.1"/><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.90.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.90.e.4"><relations><relation type="hasObject"><labelDrug text="TOPROLXL"/><normalization/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="4" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93" lineNumber="124" text="Catecholamine depleting drugs (eg, reserpine, monoamine oxidase (MAO) inhibitors) may have an additive effect when given with beta-blocking agents. " type="regular"><entity charOffset="0:29" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.1" text="Catecholamine depleting drugs" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="Catecholamine depleting drugs" preferredWord="Catecholamines" semType="phsu, nsba"/><mmtx cui="C0013227" phraseText="Catecholamine depleting drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C3536742" phraseText="Catecholamine depleting drugs" preferredWord="Catecholamine [EPC]" semType="phsu"/><mmtx cui="C0013227" phraseText="Catecholamine depleting drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="1437132"/></Normalization></entity><entity charOffset="35:44" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.2" text="reserpine" type="Drug"><Normalization><mmtx cui="C0035179" phraseText="reserpine," preferredWord="Reserpine" semType="phsu, orch"/><RxNorm RxCui="9260"/></Normalization></entity><entity charOffset="46:63" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.4" text="monoamine oxidase" type="Drug"><Normalization><mmtx cui="C0026457" phraseText="monoamine oxidase (MAO) inhibitors" preferredWord="Monoamine Oxidase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1565"/></Normalization></entity><entity charOffset="94:109" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.6" text="additive effect" type="Increase_Interaction"/><entity charOffset="126:146" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.7" text="beta-blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="given with beta-blocking agents." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><drugClassMembership drug="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.2" drugClass="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.1"/><drugClassMembership drug="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.4" drugClass="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.1"/><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.7"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.1" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.7" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.93.e.6" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94" lineNumber="124" text="Observe patients treated with TOPROL-XL plus a catecholamine depletor for evidence of hypotension or marked bradycardia, which may produce vertigo, syncope, or postural hypotension." type="regular"><entity charOffset="86:97" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="30:39" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.2" text="TOPROL-XL" type="Drug"><Normalization><mmtx cui="C0723783" phraseText="treated with TOPROL-XL" preferredWord="Toprol-XL" semType="phsu, orch"/><RxNorm RxCui="220348"/></Normalization></entity><entity charOffset="47:69" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.3" text="catecholamine depletor" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="plus a catecholamine depletor" preferredWord="Catecholamines" semType="phsu, nsba"/><mmtx cui="C3536742" phraseText="plus a catecholamine depletor" preferredWord="Catecholamine [EPC]" semType="phsu"/><RxNorm RxCui="1437132"/></Normalization></entity><entity charOffset="108:119" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.5" text="bradycardia" type="Specific_Interaction"/><entity charOffset="160:180" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.7" text="postural hypotension" type="Specific_Interaction"/><entity charOffset="139:146" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.9" text="vertigo" type="Specific_Interaction"><Normalization><mmtx cui="C0042571" phraseText="vertigo," preferredWord="Vertigo" semType="sosy"/></Normalization></entity><entity charOffset="148:155" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.11" text="syncope" type="Specific_Interaction"><Normalization><mmtx cui="C0039070" phraseText="syncope," preferredWord="Syncope" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.1"><relations><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.ddi.2"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.5"><relations><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.ddi.3"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.7"><relations><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.ddi.4"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.9"><relations><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.ddi.5"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.11"><relations><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.3" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.94.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="6" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96" lineNumber="128" text="Drugs that inhibit CYP2D6 such as quinidine, fluoxetine, paroxetine, and propafenone are likely to increase metoprolol concentration. " type="regular"><entity charOffset="0:25" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.1" text="Drugs that inhibit CYP2D6" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="Drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="34:43" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.2" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="CYP2D6 such as quinidine," preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="45:55" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.4" text="fluoxetine" type="Drug"><Normalization><mmtx cui="C0016365" phraseText="fluoxetine," preferredWord="Fluoxetine" semType="phsu, orch"/><RxNorm RxCui="227224"/></Normalization></entity><entity charOffset="57:67" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.6" text="paroxetine" type="Drug"><Normalization><mmtx cui="C0070122" phraseText="paroxetine," preferredWord="Paroxetine" semType="phsu, orch"/><RxNorm RxCui="32937"/></Normalization></entity><entity charOffset="73:84" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.8" text="propafenone" type="Drug"><Normalization><mmtx cui="C0033429" phraseText="propafenone" preferredWord="Propafenone" semType="phsu, orch"/><RxNorm RxCui="8754"/></Normalization></entity><entity charOffset="99:107|119:132" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.10" text="increase concentration" type="Increase_Interaction"/><entity charOffset="108:118" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.11" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="metoprolol concentration." preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><drugClassMembership drug="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.2" drugClass="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.1"/><drugClassMembership drug="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.4" drugClass="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.1"/><drugClassMembership drug="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.6" drugClass="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.1"/><drugClassMembership drug="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.8" drugClass="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.1"/><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.10"><relations><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.11"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.1" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.11" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.96.e.10" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97" lineNumber="128" text="In healthy subjects with CYP2D6 extensive metabolizer phenotype, coadministration of quinidine 100 mg and immediate-release metoprolol 200 mg tripled the concentration of S-metoprolol and doubled the metoprolol elimination half-life. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="173:183" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.4" text="metoprolol" type="Drug"/><antecedentEntity charOffset="106-134" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.9" text="immediate-release metoprolol" type="Drug"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="200:210" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.7" text="metoprolol" type="Drug"/><antecedentEntity charOffset="106-134" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.9" text="immediate-release metoprolol" type="Drug"/></anaphoraRelation><entity charOffset="142:167" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.1" text="tripled the concentration" type="Increase_Interaction"/><entity charOffset="3:63" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.2" text="healthy subjects with CYP2D6 extensive metabolizer phenotype" type="SPAN"/><entity charOffset="85:94" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.3" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="coadministration of quinidine 100 mg" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="173:183" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.4" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="the concentration of S-metoprolol" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="188:199|211:232" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.6" text="doubled the elimination half-life" type="Increase_Interaction"/><entity charOffset="200:210" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.7" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="the metoprolol elimination half-life." preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="106:134" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.9" text="immediate-release metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="immediate-release metoprolol 200 mg" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="729530"/></Normalization></entity><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.1"><relations><relation type="hasContext"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.ddi.2"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.6"><relations><relation type="hasContext"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.7"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.2" ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.4" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.1" type="Increase_Interaction"/><pair context="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.2" ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.7" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.97.e.6" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98" lineNumber="128" text="In four patients with cardiovascular disease, coadministration of propafenone 150 mg t.i.d. with immediate-release metoprolol 50 mg t.i.d. resulted in two- to five-fold increases in the steady-state concentration of metoprolol. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="216:226" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.2" text="metoprolol" type="Drug"/><antecedentEntity charOffset="97-125" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.7" text="immediate-release metoprolol" type="Drug"/></anaphoraRelation><entity charOffset="164:212" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.1" text="fold increases in the steady-state concentration" type="Increase_Interaction"/><entity charOffset="216:226" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.2" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="increases in the steady-state concentration of metoprolol." preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="3:16" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.3" text="four patients" type="SPAN"/><entity charOffset="22:44" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.4" text="cardiovascular disease" type="SPAN"><Normalization><mmtx cui="C0007222" phraseText="with cardiovascular disease," preferredWord="Cardiovascular Diseases" semType="dsyn"/></Normalization></entity><entity charOffset="66:77" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.5" text="propafenone" type="Drug"><Normalization><mmtx cui="C0033429" phraseText="coadministration of propafenone 150 mg t.i.d." preferredWord="Propafenone" semType="phsu, orch"/><RxNorm RxCui="8754"/></Normalization></entity><entity charOffset="97:125" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.7" text="immediate-release metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="with immediate-release metoprolol 50 mg t.i.d." preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="729530"/></Normalization></entity><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.1"><relations><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.2"/></relation><relation type="hasEvidence"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.4" ddi="true" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.5" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.2" evidence="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.3" trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.98.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.100" text="7.3 Digitalis, Clonidine, and Calcium Channel Blockers" type="negative"><entity charOffset="15:24" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.100.e.0" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="Clonidine," preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="30:54" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.100.e.1" text="calcium channel blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0006684" phraseText="Calcium Channel Blockers" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="4:13" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.100.e.2" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="7.3 Digitalis," preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.100.e.0" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.100.e.1"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.100.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.100.e.0"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.100.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.100.e.1"/></sentence><sentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101" text="Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. " type="negative"><entity charOffset="22:31" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.0" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="clonidine," preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="33:42" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.1" text="diltiazem" type="Biomedical_Entity"><Normalization><mmtx cui="C0012373" phraseText="diltiazem" preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="47:56" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.2" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="verapamil slow atrioventricular conduction" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="0:20" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.3" text="digitalis glycosides" type="Biomedical_Entity"><Normalization><mmtx cui="C0012253" phraseText="Digitalis glycosides," preferredWord="Digitalis Glycosides" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.0" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.1"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.0" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.2"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.0"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.1" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.2"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.1"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.102" lineNumber="132" text="Concomitant use with beta blockers can increase the risk of bradycardia." type="irregular"><entity charOffset="60:71" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.102.e.1" text="bradycardia" type="Specific_Interaction"/><entity charOffset="21:34" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.102.e.2" text="beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="Concomitant use with beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.102.ddi.1"><interaction trigger="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.102.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101" text="Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. "><entity charOffset="0:20" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.2" text="Digitalis glycosides" type="Drug_Class"><Normalization><mmtx cui="C0012253" phraseText="Digitalis glycosides," preferredWord="Digitalis Glycosides" semType="phsu, carb"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101" text="Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. "><entity charOffset="33:42" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.1" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem" preferredWord="Diltiazem" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101" text="Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. "><entity charOffset="47:56" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil slow atrioventricular conduction" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.102.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101" text="Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. "><entity charOffset="22:31" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.101.e.3" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="clonidine," preferredWord="Clonidine" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103" text="If clonidine and a beta blocker, such as metoprolol are coadministered, withdraw the beta-blocker several days before the gradual withdrawal of clonidine because beta-blockers may exacerbate the rebound hypertension that can follow the withdrawal of clonidine. " type="negative"><entity charOffset="162:175" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.0" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="144:153" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.1" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="the beta-blocker several days before the gradual withdrawal of clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="41:51" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.2" text="metoprolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0025859" phraseText="such as metoprolol" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="85:97" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.3" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="the beta-blocker several days before the gradual withdrawal of clonidine" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="3:12" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.4" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="19:31" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.5" text="beta blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="a beta blocker," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="250:259" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.6" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="the withdrawal of clonidine." preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.1" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.0"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.0"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.4" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.0"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.0" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.6"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.1"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.1"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.5" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.1"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.3"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.4" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.2"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.5" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.2"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.6"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.4" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.3"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.6"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.4" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.5"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.5" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.103.e.6"/></sentence><sentence id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104" text="If replacing clonidine by beta-blocker therapy, delay the introduction of beta-blockers for several days after clonidine administration has stopped see Warnings and Precautions (5.11)." type="negative"><entity charOffset="111:120" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.0" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="after clonidine administration" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="26:38" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.1" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="replacing clonidine by beta-blocker therapy," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="74:87" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.2" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="the introduction of beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="13:22" id="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.3" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="replacing clonidine by beta-blocker therapy," preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.1" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.0"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.2" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.0"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.1"/><pair ddi="false" e1="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.3" e2="Dailymed.4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4.s.104.e.2"/></sentence><positiveExamples number="14"/><negativeExamples number="44"/></document>